Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.420
+0.030 (2.16%)
Jun 3, 2026, 2:43 PM EDT - Market open
Humacyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.02 | 2.04 | - | - | 1.57 | 1.26 | |
Revenue Growth (YoY) | 289.94% | - | - | - | 23.91% | -15.29% |
Cost of Revenue | 11.59 | 9.7 | - | - | - | - |
Gross Profit | -9.58 | -7.66 | - | - | 1.57 | 1.26 |
Selling, General & Admin | 30.97 | 31.17 | 25.8 | 23.5 | 22.88 | 21.13 |
Research & Development | 73.35 | 69.3 | 88.6 | 76.55 | 63.26 | 61.34 |
Total Operating Expenses | 104.31 | 100.47 | 114.4 | 100.05 | 86.14 | 82.47 |
Operating Income | -113.89 | -108.14 | -114.4 | -100.05 | -84.58 | -81.21 |
Interest Income | 2.26 | 2.59 | 4.1 | 5.47 | 2.63 | 0.02 |
Interest Expense | -10.52 | -11.25 | -9.28 | -6.6 | -6.2 | -4.35 |
Other Non-Operating Income (Expense) | 46.83 | 75.97 | -29.13 | -9.6 | 77.75 | 60.33 |
Total Non-Operating Income (Expense) | 38.56 | 67.3 | -34.3 | -10.73 | 74.18 | 55.99 |
Pretax Income | -75.32 | -40.83 | -148.7 | -110.78 | -10.4 | -25.21 |
Net Income | -42.42 | -40.83 | -148.7 | -110.78 | -10.4 | -25.21 |
Net Income to Common | -42.42 | -40.83 | -148.7 | -110.78 | -10.4 | -25.21 |
Shares Outstanding (Basic) | 175 | 158 | 118 | 103 | 103 | 40 |
Shares Outstanding (Diluted) | 175 | 158 | 118 | 103 | 103 | 40 |
Shares Change (YoY) | 40.43% | 33.49% | 14.56% | 0.36% | 157.82% | - |
EPS (Basic) | -0.57 | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 |
EPS (Diluted) | -0.57 | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 |
Shares Outstanding | 222.02 | 193 | 130.03 | 103.67 | 103.23 | 103 |
Free Cash Flow | -102.38 | -105.93 | -99.69 | -75.59 | -72.18 | -81.41 |
Free Cash Flow Per Share | -0.59 | -0.67 | -0.84 | -0.73 | -0.70 | -2.04 |
Gross Margin | -475.05% | -376.06% | - | - | 100.00% | 100.00% |
Operating Margin | -5649.21% | -5306.04% | - | - | -5404.35% | -6429.77% |
Profit Margin | -2104.32% | -2003.58% | - | - | -664.54% | -1996.36% |
FCF Margin | -5078.17% | -5197.55% | - | - | -4611.95% | -6445.76% |
EBITDA | -106.59 | -100.79 | -107.21 | -92.33 | -76.37 | -72.97 |
EBITDA Margin | -5286.95% | -4945.63% | - | - | -4879.74% | -5777.28% |
EBIT | -113.89 | -108.14 | -114.4 | -100.05 | -84.58 | -81.21 |
EBIT Margin | -5649.21% | -5306.04% | - | - | -5404.35% | -6429.77% |